8-AHA-CAMP(39824-30-1)
- Name: 8-AHA-CAMP
- Synonyms:4H-Furo[3,2-d]-1,3,2-dioxaphosphorin,adenosine deriv.; 8-(6-Aminohexylamino)-cAMP
- Molecular Formula:C16H26 N7 O6 P
- Molecular Weight:443.399
- CAS Registry Number:39824-30-1
- EINECS:
- Melting Point:
- Water Solubility:dilute NaOH: soluble
CAS No.39824-30-1 8-AHA-CAMP
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.39824-30-1 8-AHA-CAMP
Assay:99% Application:api
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.39824-30-1 8-AHA-CAMP
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:8-AHA-CAMP
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.39824-30-1 8-AHA-cAMP
Assay:鈮?98% by HPLC Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 62043-04-3/6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]- diazepine-9-methanamine,2-chloro-4-(2- chlorophenyl)-,monohydrochloride
- 68409-65-4/Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy-, 2-methylpropyl ether
- 14028-29-6/1-(2-{[3-hydroxy-4-(piperidin-1-ylcarbonyl)phenyl]amino}-2-oxoethyl)piperidinium chloride
- 60049-54-9/2-[(4-methoxynaphthalen-1-yl)methyl]benzoic acid
- 68869-50-1/5-[(biphenyl-4-yloxy)methyl]-4-(4-bromophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
- 7470-79-3/6-[2-amino-4-(dimethylamino)benzyl]-N,N,4-trimethylbenzene-1,3-diamine
- 66536-94-5/Metariboadenosine triphosphate drops
- 124433-97-2/diethyl (4-cyanophenoxy)propanedioate
- 20800-18-4/1-[2-(2-butanoylphenoxy)ethyl]piperidinium chloride
- 73052-29-6/2(1H)-Quinazolinone,1-(cyclopropylmethyl)-4- (4-hydroxyphenyl)-6-methoxy-
- 107167-31-7/lactivicin
- 93553-57-2/4-[3-(3,5-dibromophenyl)-2,5-dioxopyrrolidin-1-yl]benzenesulfonamide
- 149881-63-0/Naphtho[1,2-b]furan-6,9-dione,2,3-dihydro-4-hydroxy-3-[(2E)-4-hydroxy-4-methyl-2-penten-1-yl]-7-methoxy-2,3,8-trimethyl-,(2R,3S)-rel-(-)-
- 117654-53-2/diundecyl 4-[2-(difluoromethoxy)phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
- 41363-21-7/methyl 4-{[(4-{[bis(aziridin-1-yl)phosphoryl]oxy}phenyl)carbamoyl]oxy}benzoate
- 677-69-0/Heptafluoroisopropyl iodide
- 68679-99-2/1,1'-(dichlorovinylidene)bis[chlorobenzene]
- 21173-27-3/2-(4-methylphenyl)ethyl pyridine-3-carboxylate
- 69136-68-1/Phenol,2-(1-methylethoxy)-,methylcarbamate,mixt. with 6,7,8,9,10,10-hexachloro-1,5,5a,6,9,- 9a-hexahydro-6,9-methano-2,4,3-benzodioxathiepin 3-oxide
- 39824-30-1/8-AHA-CAMP
- 142808-30-8/Lanost-9(11)-ene,21,24-epoxy-24-methyl-, (24R)- (9CI)
- 1993-23-3/(1E)-1-[(3beta,16E)-3-(acetyloxy)-17-oxoandrost-5-en-16-ylidene]-2,2,2-trifluoroethyl acetate
- 7058-90-4/3,3'-(cyanoimino)bis-
- 112617-43-3/Cosulfadimidine
- 123089-28-1/[(E)-2-chloroethenyl](oxo)arsane
- 86273-92-9/Tolufazepam
- 58344-24-4/(2E)-3-(1,3-benzodioxol-5-yl)-1-tert-butylprop-2-en-1-yl thiophene-2-carboxylate
- 137497-38-2/midkine
- 133872-43-2/glycyl]glycyl]glycyl]glycyl]-L-valyl]-
- 916-85-8/hexabutyl 1,3,5-triazine-2,4,6-triyltris(phosphonate)